Companies / BIO

BIOME AUSTRALIA LIMITED

ASX:BIOHousehold & Personal Products
228.0M shares on issueASX (delayed) · as of 28 July 2026$0.27price · delayed$58.1Mmarket cap · indicative
C
Dilution grade

Runway under 2 quarters; share count grew 6% in 24 months

Cash runway1.2 quarters of funding
Share-count growth (24m)5.9%
Raise cadence (24m)0 cash raises
Options & rights overhang0.0% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

BIOME AUSTRALIA LIMITED's ordinary share count was 228M as of March 2026, up 5.9% since July 2024. The company did not raise capital in the most recent 24-month window. At the March 2026 quarter BIOME AUSTRALIA LIMITED reported A$1.6M in available cash, equal to about 1.2 quarters of funding at its recent spending rate. There are no proposed securities issues (Appendix 3B) currently pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
0.0%
Max option dilution
0.0%
ITM option dilution
0
Raises · last 12 months
1.2 qtrs
Cash cover · under 2 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 228.0M per ASX (delayed) (28 July 2026).
221.0M223.6M226.1MDec 24Sept 25July 26

Cash runway

1.2 qtrs
Less than two quarters of funding at the recent spend rate — near-term funding pressure.
$1.6M available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 31 Mar 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
1 Apr 20263H · cancellationBIO : ORDINARY FULLY PAID228.0MAppendix 3H
30 Mar 20262A · quoted issueBIO : ORDINARY FULLY PAID228.0MAppendix 2A
19 Mar 20262A · quoted issueBIO : ORDINARY FULLY PAID227.0MAppendix 2A
19 Mar 20262A · quoted issueBIO : ORDINARY FULLY PAID224.5MAppendix 2A
17 Mar 20262A · quoted issueBIO : ORDINARY FULLY PAID224.5MAppendix 2A
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

No equity raises in the last 24 months.
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

No options or rights over unissued shares on record.

Director dealings

DateDirectorTypeSharesOptionsValueSource
25 June 2026Blair Vega NorfolkBuy100k—$25k3Y notice
12 June 2026Geoffrey SamBuy72k—$20k3Y notice
10 June 2026Blair Vega NorfolkBuy100k—$27k3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

26 July 2026$PInternational Markets Presentation
26 July 2026Investor Webinar
30 June 2026$PFY26 Trading Update
25 June 2026Change of Director's Interest Notice
12 June 2026Change of Director's Interest Notice
12 June 2026Ceasing to be a substantial holder
10 June 2026Change of Director's Interest Notice
3 June 2026Change of Director's Interest Notice
2 June 2026$PBiome Signs Australian Manufacturing Agreement
2 June 2026Biome Investor Presentation June 2026
26 May 2026Investor Webinar
26 May 2026$PBMB18 clinical trial expands to dual site
11 May 2026$PProbiotical Exclusive Supply Agreement Extended
29 Apr 2026Change of Director's Interest Notice
28 Apr 2026Change of Director's Interest Notice
28 Apr 2026Revised Appendix 4C Quarterly Cash Flow Report
27 Apr 2026$PQuarterly Activities & Cashflow Report
26 Apr 2026$PPatent Application Filed for Probiotic Strain BMB18
10 Apr 2026Change of Auditor
1 Apr 2026Notification of cessation of securities - BIO

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.